RxSS Member Engagement Managers Lauren Winchester and Ann Havermann share how they support clients and empower members across the country.
Promoting Action and Partnership: A Closer Look at RxSS Member Engagement Read More »
Our takeaways from the 2025 Medication Access Report from CoverMyMeds. Learn about the reasons behind the barriers to medication access.
10 Takeaways from the 2025 Medication Access Report Read More »
Our panel of frontline RxSS Roundtable experts weighs in on key issues for payers and patients in 2025—from a political, clinical and practical perspective.
Drug Trends and Shifting Landscapes in 2025 and Beyond Read More »
Listen to the conversation on the evolving pharmacy landscape for 2025 with Eileen Murphy, Director of Pharmacy for Security Health Plan.
Navigating Pharmacy’s Future: Strategies for 2025 Read More »
The latest Medicare Star changes require plan sponsors to maintain focus when it comes to creative thinking and pioneering progress.
Medicare Star Changes Invite Continued Innovation Amid Economic Headwinds Read More »
RxSS pharmacists may work on our products, support sales, help clients achieve their goals, or assist members on the front lines and behind the scenes.
Pharmacist Roots Run Deep and Spread Beyond the Counter at RxSS Read More »
Big changes are coming for Medicare Part D plan sponsors and enrollees. Learn where key opportunities may exist for payers amid the transformation.
RxSS member support comes from pharmacy technicians who go all out to find affordable prescriptions and deliver peace of mind.
RxSS Member Support – Savings and Satisfaction in One Call or Click Read More »
Up to 10 competing products for Humira are on the way in 2023. What should health plans and plan sponsors be following as the biosimilars landscape takes shape?
The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus Read More »
The Inflation Reduction Act has the potential to lower prescription drug costs for millions of Americans and raise them for millions more. Who stands to gain or lose?
